Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy

scientific article published on 01 March 2005

Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1253/CIRCJ.69.283
P698PubMed publication ID15731532

P2093author name stringYoshihiko Seino
Kazuteru Funahashi
Mitsuru Suwa
Shinsuke Matsuki
Yoshikata Nomachi
P433issue3
P921main subjectheart failureQ181754
acute decompensated heart failureQ4677930
P304page(s)283-290
P577publication date2005-03-01
P1433published inCirculation JournalQ1955928
P1476titleMulticenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy
P478volume69

Reverse relations

cites work (P2860)
Q33618498ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha
Q48179076ANP is cleared much faster than BNP in patients with congestive heart failure
Q34643664Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide
Q98944124Association between NPPA promoter methylation and hypertension: results from Gusu cohort and replication in an independent sample
Q91588858Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease
Q38816005Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.
Q37249880Atrial natriuretic peptide down-regulates neutrophil recruitment on inflamed endothelium by reducing cell deformability and resistance to detachment force
Q36860608Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions
Q47717243Circadian Regulation of Renal Function.
Q49151463Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
Q41141539Comparison of the Effects of Carperitide and Tolvaptan on Patients with Left Ventricular Dysfunction: A Two-Center Retrospective Study.
Q37058407Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy
Q35086479Designer natriuretic peptides
Q83965872Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes
Q89324590Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses
Q36664047Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
Q47893208Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure
Q92641654Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction
Q35046791Genetic variation in the natriuretic peptide system and heart failure
Q30469953Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization
Q53519480Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide.
Q33653332Innovative Therapeutics: Designer Natriuretic Peptides
Q37329891Modulation of cGMP in heart failure: a new therapeutic paradigm
Q26827702Natriuretic Peptides and Cardiometabolic Health
Q38371173Natriuretic Peptides as a Novel Target in Resistant Hypertension
Q36794409Natriuretic peptides and therapeutic applications
Q90182838Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Q38202895Novel drug targets in clinical development for heart failure.
Q38072635Novel vasodilators in heart failure
Q38360688Privileged frameworks from snake venom.
Q36054705Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides
Q36140769Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes
Q37900203Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment
Q37703738The heart as an endocrine organ.
Q37286819The role of atrial natriuretic peptide to attenuate inflammation in a mouse skin wound and individually perfused rat mesenteric microvessels

Search more.